TSHA (Taysha Gene Therapies Inc) Nilai bisnis marang pendapatan

Logo perusahaan publik Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies (TSHA) adheres to research bioethics and reduces its carbon footprint by applying green chemistry principles for the safe disposal of reagents. The current EV/Sales ratio demonstrates the asset's valuation dynamics, where the 153863.39 metric determines the parameter status. The development prospects for this rare pathology therapy ecosystem depend directly on pricing and FDA approvals.

TSHA (Taysha Corp) riwayat Multiplikator EV/Sales saka 23.11.2025 nganti 21.11.2026

TSHA (Taysha): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:TSHA - tayshagtx.com
Barang utama Taysha Gene Therapies Inc

This indicator compares the total enterprise value to annual sales volume, excluding the impact of debt load. It allows for the determination of the degree of overpayment for an asset during periods of market optimism. By analyzing the EV/Sales multiple, an investor identifies the gap between the market price and the actual efficiency of the business. For Taysha Gene Therapies (TSHA), such a valuation is critical, as the value of the CNS gene therapy ecosystem is often based on future expectations for the treatment of Rett syndrome.

Analisis pesaing

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|QURE - Rasio nilai perusahaan marang pendapatan|MeiraGTx Holdings (MGTX) - Nilai perusahaan marang pendapatan|Regenxbio (RGNX) - Rasio nilai perusahaan marang pendapatan|SLDB - Rasio total nilai perusahaan marang pendapatan|OCGN (Ocugen Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PACB|Rasio nilai perusahaan marang pendapatan Benitec (BNTC)|Design Therapeutics Inc - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rocket Pharma RCKT|Multiplikator EV/Sales 4DMT FDMT|LXEO - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Korro Bio Inc.|EDIT: Multiplikator EV/Sales|SLN - Rasio total nilai perusahaan marang pendapatan|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan